Clinical Trial Update: A Clinical Study to Compare the Safety and Efficacy of an Aliskiren-based Regimen With a Lisinopril Based Regimen in Patients With Severe Hypertension [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial comparing an aliskiren-based regimen with a lisinopril-based regimen for severe hypertension has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• Aliskiren (Aliskiren)
• Lisinopril (Lisinopril)

Snippet

Sponsor: Novartis | Conditions: Hypertension | Phase 3 | Status: COMPLETED